Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Womer

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Pediatric Blood & Cancer|January 31, 2004
An examination of outcome measures to assess functional mobility in childhood survivors of osteosarcomaVictoria G Marchese, Susan Ogle, Richard B Womer, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2003
Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomasChanghu Chen, Hui Kuo G Shu, Joel W Goldwein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gainsRichard B Womer, Ellen Tracy, Winson Soo-Hoo, et al.
Pediatric Blood & Cancer|May 17, 2017
Dosing anticancer drugs in infants: Current approach and recommendations from the Children's Oncology Group's Chemotherapy Standardization Task ForceFrank M Balis, Richard B Womer, Stacey Berg, et al.
Pediatric Blood & Cancer|October 30, 2004
Early molecular detection of central nervous system relapse in a child with systemic anaplastic large cell lymphoma: case report and review of the literatureGregory Armstrong, Arpad Szallasi, Jaclyn A Biegel, et al.
Frontiers in Oncology|June 14, 2013
Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology GroupNeerav Shukla, Joshua Schiffman, Damon Reed, et al.
Sarcoma|October 29, 2015
Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group ReportNeyssa Marina, Linda Granowetter, Holcombe E Grier, et al.
Pediatric Blood & Cancer|September 17, 2015
Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology GroupMichael S Isakoff, Robert Goldsby, Doojduen Villaluna, et al.
Pediatric Blood & Cancer|February 16, 2019
Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal functionPeter C Adamson, Gareth J Veal, Richard B Womer, et al.
Journal of Pediatric Hematology/Oncology|December 15, 2017
Management of Refractory Pediatric Kaposiform Hemangioendothelioma With Sirolimus and AspirinSuzanne P MacFarland, Lisa M Sullivan, Lisa J States, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Pediatric Blood & Cancer|January 31, 2004
An examination of outcome measures to assess functional mobility in childhood survivors of osteosarcomaVictoria G Marchese, Susan Ogle, Richard B Womer, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2003
Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomasChanghu Chen, Hui Kuo G Shu, Joel W Goldwein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gainsRichard B Womer, Ellen Tracy, Winson Soo-Hoo, et al.
Pediatric Blood & Cancer|May 17, 2017
Dosing anticancer drugs in infants: Current approach and recommendations from the Children's Oncology Group's Chemotherapy Standardization Task ForceFrank M Balis, Richard B Womer, Stacey Berg, et al.
Pediatric Blood & Cancer|October 30, 2004
Early molecular detection of central nervous system relapse in a child with systemic anaplastic large cell lymphoma: case report and review of the literatureGregory Armstrong, Arpad Szallasi, Jaclyn A Biegel, et al.
Frontiers in Oncology|June 14, 2013
Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology GroupNeerav Shukla, Joshua Schiffman, Damon Reed, et al.
Sarcoma|October 29, 2015
Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group ReportNeyssa Marina, Linda Granowetter, Holcombe E Grier, et al.
Pediatric Blood & Cancer|September 17, 2015
Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology GroupMichael S Isakoff, Robert Goldsby, Doojduen Villaluna, et al.
Pediatric Blood & Cancer|February 16, 2019
Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal functionPeter C Adamson, Gareth J Veal, Richard B Womer, et al.
Journal of Pediatric Hematology/Oncology|December 15, 2017
Management of Refractory Pediatric Kaposiform Hemangioendothelioma With Sirolimus and AspirinSuzanne P MacFarland, Lisa M Sullivan, Lisa J States, et al.
Pageof 6